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ABSTRACT: We are pursuing a dual strategy for investigating the chemistry of nitric oxide as a 
biological signaling agent. In one approach, metal-based fluorescent sensors for the detection of NO in 
living cells are evaluated, and a sensor based on a copper fluorescein complex has proved to be a 
valuable lead compound. Sensors of this class permit identification of NO from both inducible and 
constitutive forms of nitric oxide synthase and facilitate investigation of different NO functions in 
response to external stimuli. In the other approach, we employ synthetic model complexes of iron-sulfur 
clusters to probe their reactivity toward nitric oxide as biomimics of the active sites of iron-sulfur 
proteins. Our studies reveal that NO disassembles the Fe-S clusters to form dinitrosyl iron complexes 
(DNICs). 
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Introduction 
Nitric oxide (NO) has long been of interest to inorganic chemists because of the rich variety of 
coordination modes and spectroscopy displayed by transition metal nitrosyls.1 In addition to its 
appealing inorganic chemistry, a biological role for NO as the endothelium derived relaxation factor 
(EDRF) was identified nearly 30 years ago.2-4 NO serves as a secondary messenger by activating soluble 
guanylyl cyclase (sGC), inducing a downstream pathway that leads to vascular smooth muscle 
relaxation. The mode of action of NO involves coordination to a heme-iron in the active site of sGC.5 
Since these initial discoveries, the role of nitric oxide in biology has been studied extensively. A small 
free radical, NO elicits many physiological events.6 As for all signaling agents, NO homeostasis is 
crucial to its proper function, and misregulation of NO production is implicated in a large number of 
pathologies.6 In order to study the many roles of NO in biology, we are pursuing a dual strategy 
whereby we employ both cellular fluorescence imaging to monitor endogenously produced NO in a 
variety of biological contexts and we apply synthetic coordination chemistry to study the fundamental 
reactivity of NO with non-heme iron-sulfur complexes as biomimics of its cellular targets. Through this 
approach, we are able to probe chemical reactivity at crucial NO interaction sites under conditions of 
biological stimulation and, at the same time, introduce novel, bio-compatible visualization techniques to 
identify and establish possible new roles of NO in ex vivo systems. 
Probes for detecting nitric oxide in live cells 
Because nitric oxide is implicated in numerous biological processes significant to health and disease, 
investigating the roles of this signaling agent is critical to revealing biological function and continues to 
be an active area of research. Although many techniques are available to detect NO, including 
electrochemistry, magnetism, chemiluminescence, and absorbance, these methods often require 
electrodes or further chemical manipulations to accomplish detection. It is difficult to design such 
sensors to be suitable for direct, rapid, and resolved detection in living specimens.7 Fluorescence 
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microscopy, however, is amenable to cellular and in vivo analyte sensing. The best biologically relevant 
fluorescent probes are cell membrane permeable, non-toxic, water-soluble, and excitable at low-energy 
wavelengths that do not harm cells or cause interfering autofluorescence. Additional desirable 
photophysical properties are a large dynamic range, selectivity, diffusibility, cell-trappability, 
reversibility, and rapid response times. In the best scenario, these probes can detect nitric oxide directly 
at its biological concentrations. 
The field of NO probe design has improved dramatically over the past decades. Most new probes are 
designed with biocompatibility that renders them useful for cell, tissue, and possibly animal research. 
Despite this progress, some important goals remain to be achieved. Cell-trappability is an important 
probe feature that has been accomplished for organic NO-sensors but not metal-based NO-sensors. In 
order to understand the signaling properties of nitric oxide it would be valuable to identify the NO-
production origin and subsequent cellular paths of the molecule. Sub-cellular localization of probes 
would assist in this regard. Quantitative reactive nitrogen species (RNS) detection using ratiometric 
probes would be valuable for measuring NO production upon cellular exposure to various stimuli. A 
major issue that needs to be addressed in future probe design is reversibility, which is required to get 
true spatiotemporal resolution. To be most useful, a reversible probe should report the time-dependent 
change in local NO concentration and not include other chemical reactions that restore the probe to its 
original off state.  
Small-Molecule Fluorescent NO-sensing Strategies 
Small-molecule fluorescent nitric oxide probes fall into two main categories, organic-based and 
metal-based. The organic probes are quenched fluorophores functionalized to create a species that is 
only emissive following reaction with NO or a derivative thereof. The most widely used organic probes 
contain an o-phenylenediamine moiety (Scheme 1a).8-13 Quenching is accomplished by a photoinduced 
electron transfer (PeT) mechanism in the excited state. The electron-rich vicinal amines alter the energy 
of the frontier orbitals in such a way as to facilitate PeT. In the presence of NO oxidized to N2O3, an 
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electron-poor aryl triazole is formed, which sufficiently alters the energy of the frontier orbitals to 
abolish the PeT pathway and restore emission.14 These probes have been used extensively in biological 
experiments. A major limitation of these sensing agents, however, is the need to oxidize NO before it 
can react with the sensor, rendering them indirect detection systems unable to provide spatial or 
temporal information. Moreover, these probes are irreversible and offer no prospect for improvement in 
that regard. 
Metal-based probes take advantage of either direct NO reactivity at the metal center or reactivity at 
chelated ligand atoms.15 These probes provide an opportunity to explore direct and reversible sensing, 
because, unlike o-phenylenediamines, metals can interact reversibly with nitric oxide. Typically, metal-
ligand constructs are assembled where the fluorophore is part of the ligand. Fluorophore emission is 
quenched by one of several PeT mechanisms. There are then three main strategies for eliciting a 
fluorescence response from these quenched systems in response to NO. 
Fluorophore displacement. The simplest strategy to regain fluorophore emission is to remove it from 
the quenching site (Scheme 1b). This task can be accomplished either by releasing the ligand entirely or 
by removing a chelating arm to a sufficient distance from the metal. In both cases, ligand displacement 
accompanies nitric oxide binding to form a metal nitrosyl. Many metal-based NO-probes utilize this 
approach, including those containing Co(II),16 Fe(II),16,17 Ru(II)18 or Rh(II).19,20 
Metal reduction. Reduction of the metal to form a diamagnetic species can alleviate quenching caused 
by paramagnetic metal ions (Scheme 1c).21 Typically, this mechanism operates in protic solvents (ROH) 
and results in transfer of NO to the solvent to form an alkyl nitrite (RONO). This strategy has been 
employed primarily with Cu(II) probes, which are readily reduced by NO but fail to form stable Cu(I)-
NO species.22,23 Copper(II) has also been incorporated into conjugated polymers to fashion NO-sensitive 
films using the intrinsic fluorescence of the polymer as the emitter.24-26 This tactic accommodates a wide 
range of modifications, such as incorporating water-soluble functional groups to facilitate biological 
compatibility.27 
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Fluorophore displacement and metal reduction. A third mechanism for restoring fluorescence 
emission is both to displace the fluorophore and to reduce the paramagnetic metal center by reductive 
nitrosylation (Scheme 1d). In this process, NO can either coordinate to the metal28-30 or nitrosate either 
the ligand or solvent, when the latter is protic.31-34 The first example of this approach involved a 
paramagnetic cobalt(II) aminotroponiminate complex incorporating a dansyl fluorophore as part of the 
ligand.28 Upon reaction with NO in dichloromethane, one of the chelating arms was displaced and a 
diamagnetic cobalt-dinitrosyl complex formed. This reaction was accompanied by an ~8-fold emission 
enhancement over the course of 6 h. This strategy remains the most promising for biological NO 
detection and is further discussed below. 
Biologically Relevant Direct NO Detection 
A fluorescent nitric oxide probe employing the third metal-based sensing strategy is CuFL1 (Scheme 
2), a molecule that can detect NO in live cells.31,32 The advantages of this probe are its brightness, cell 
membrane permeability, minimal cytotoxicity, selectivity, and rapid fluorescent enhancement in the 
presence of NO. Upon exposure to excess nitric oxide, there is an immediate 11±2-fold increase in 
fluorescence that is complete within 5 min (16±1-fold total fluorescence enhancement).31,32 CuFL1 is 
selective for NO over a wide range of reactive oxygen and nitrogen species (RONS), including nitrate, 
nitrite, hydrogen peroxide, hypochlorite, peroxynitrite, superoxide, and nitroxyl.31 Importantly, 
endogenously produced NO can be visualized using CuFL1 in both iNOS- and cNOS-expressing cell 
lines in a time-dependent fashion when incubated with the appropriate NOS-inducing agent (Figure 1).32 
Recently, a Cu(II) complex of 4-methoxy-2-(1H-naphtho[2,3-d]imidazol-2-yl)phenol (MNIP) operating 
by the same mechanism as CuFL1 was employed as a NO-specific probe in liver slices to study NO-
induced inflammation during hepatic injury,35 demonstrating the applicability of this strategy in ex vivo 
tissue experiments. 
The mechanism by which fluorescence enhancement occurs when CuFL1 is exposed to nitric oxide 
involves nitrosation of the secondary amine of the ligand and loss of copper. The ligand by itself is only 
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weakly fluorescent. DFT calculations suggest that quenching of FL1 is due to PeT from one of the lone 
pair electrons on the aminoquinaldine into a half-filled fluorescein molecular orbital in the excited 
state.31 This electron-transfer event is possible because the lone pair of the aniline nitrogen atom on the 
quinoline (HOMO-1 orbital) occupies an sp3 orbital that is similar in energy to that of the HOMO orbital 
(Figure 2a).31 In the excited state, when electronic relaxation of the HOMO orbital occurs, the HOMO-1 
orbital remains largely undisturbed because the nitrogen lone pair is delocalized onto the quinoline ring 
and increases in energy due to π-antibonding interactions (Figure 2b).31 As a result, the HOMO-1 orbital 
is higher in energy than the half-filled HOMO orbital in the excited state and therefore a competent 
donor orbital for PeT quenching. The emission of the ligand is further reduced when it forms a Cu(II) 
complex, due to the quenching by the paramagnetic center. Fluorescence studies confirmed that it is the 
CuFL1 complex, not the FL1 ligand, which senses NO. EPR experiments revealed that Cu(II) is reduced 
to Cu(I) during the reaction, but formation of a diamagnetic metal species alone is not responsible for 
the fluorescence enhancement because of PeT-induced self-quenching of the ligand.31,32 LC-MS and 
UV-vis studies of the product of the reaction revealed that Cu(I) is released and an N-nitrosated version 
of the ligand, FL1-NO, is formed.31,32 MS and UV-vis spectroscopic characterization of independently 
synthesized FL1-NO corroborated these results. 15N NMR spectral characterization of the product of the 
reaction of FL1 with 15NO2 under acidic conditions confirmed that the ligand could be nitrosated at the 
secondary amine to produce an emissive derivative, FL1-NO.31,32 The quantum yield of FL1-NO is 7.5-
fold greater than that of FL1 and 9.2-fold greater than that of the copper complex, supporting the 
conclusion that FL1-NO is the species responsible for the fluorescence emission in these reactions.31,32 
DFT calculations confirmed that FL1-NO has lost the ability to self-quench. When the aniline nitrogen 
atom is nitrosated, it adopts a trigonal planar geometry (Figure 2a), causing the molecular orbital 
containing the lone pair of the quinoline (HOMO-14 orbital) to be much lower in energy than in the un-
nitrosated version (Figure 2b).31 The interaction of the lone pair on the aniline nitrogen atom with the π-
system of the quinoline ring is attenuated by comparison to the situation in FL1. Instead, it delocalizes 
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into the π-system of the formally NO+ fragment, producing a stabilized NO moiety of lower energy.31 It 
is assumed that this situation will also apply to the excited state, which would cause FL1-NO to emit.31 
There is more than one plausible intimate mechanism for this reaction. It is possible that, upon 
exposure of CuFL1 to NO, a transient copper-nitrosyl forms with attendant reduction of Cu(II) to Cu(I) 
and oxidation of NO to NO+. Upon deprotonation of the ligand aniline nitrogen atom, the NO+ would 
nitrosate the amine, resulting in ligand dissociation from the metal (Scheme 3a). It is possible that, 
instead of direct Cu(II)-NO bond formation, outer sphere electron transfer from NO occurs to reduce 
Cu(II) to Cu(I), forming NO+, which reacts with the ligand upon deprotonation. An alternative 
mechanism involves initial deprotonation of the aniline nitrogen atom, followed by attack of NO at that 
site to form the N-nitrosamine. Subsequent inner-sphere electron transfer to copper by the coordinated 
amido ligand would result in reduction to Cu(I) and ligand dissociation (Scheme 3b). Another possible 
result of ligand deprotonation is conversion of the resulting Cu(II)-NR2 to an aminyl radical Cu(I)–·NR2 
species, which would readily react with NO.36 The mechanism by which a copper(II) dianthracenyl-
cyclam complex (CuDAC) reacts with NO in a manner similar to CuFL1 has been investigated.33,34 
CuDAC, like CuFL1, is non-emissive in the absence of NO, but in its presence fluoresces due to 
reduction of the paramagnetic Cu(II) center. Like CuFL1, the DAC ligand is N-nitrosated and 
dissociates from the metal center after reaction with NO.34 The reaction of CuDAC and NO is pH-
dependent, and no copper-nitrosyl was observed during infrared studies of the complex.34 These results 
support a reaction mechanism like the second postulated scenario for CuFL1 (Scheme 3b).  
Application of CuFL1: Determination of NO as a Virulence Factor in Bacillus anthracis 
Most nitric oxide produced in vivo is generated by the enzyme nitric oxide synthase (NOS), which 
converts L-arginine to L-citrulline and NO via N-hydroxy-L-arginine.37 In eukaryotes, there are two 
major classes of the enzyme (euNOSes), constitutive and inducible, which produce different 
concentrations of NO after induction by different stimuli.38 Neuronal (nNOS) and endothelial (eNOS) 
nitric oxide synthases represent the constitutive forms of the enzyme (cNOS). They require activation to 
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produce NO, a process that occurs after an increase in the intracellular Ca2+ ion concentration activates 
calmodulin (CaM). Calcium binding to CaM induces a conformational change in this protein, which 
primes it for subsequent action on a variety of targets, including nNOS and eNOS, activating their 
catalytic functions.39,40 The NO-forming reaction occurs in the oxidase domain of cNOSes, which 
contains a heme responsible for L-arginine hydroxylation. A reductase domain supplies electrons 
required for turnover. The electrons are shuttled from flavin moieties in the reductase to the heme center 
after calmodulin binding alters the protein conformation to bring the oxidase and reductase domains into 
close proximity.39 Recently, a NOS from the Gram-negative bacterium Sorangium cellulosum has been 
isolated that is similar to eukaryotic NOSes.41 This enzyme uses a 2Fe2S ferrodoxin domain in the 
reductase instead of flavins to transfer electrons, and it utilizes either tetrahydrobiopterin (H4B) or 
tetrahydrofolate (H4F) as cofactors, rather than only H4B in the euNOSes.41 Many Gram-positive 
bacteria also express a nitric oxide synthase, bNOS, which contains an oxidase that is homologous to 
that of the euNOSes. These enzymes differ from the eukaryotic ones because they lack a reductase 
domain in the protein. As a result, it was long thought that bNOS-expressing bacteria were incapable of 
producing NO in vivo. However, NO production has been demonstrated by three Gram-positive 
bacteria, Bacillus subtilis, Bacillus anthracis, and Staphylococcus aureus.42-44 It is hypothesized that 
these bNOS-expressing bacteria recruit non-committed reductases to provide electrons for catalysis.42  
Anthrax infection is caused by Bacillus anthracis, one of the NO-generating bacteria. Cutaneous, 
gastrointestinal, and inhalation anthrax infections are all potentially fatal, but inhalation anthrax is the 
most deadly because of its ease of spread, rapid uptake into the body, and potent action. When these 
bacteria enter the body they are taken up by the host’s macrophage cells, which attempt to kill the 
bacteria by attacking them with an onslaught of reactive oxygen species including hydrogen peroxide 
and hydroxyl radical. B. anthracis is potent in part because it can defend itself against such an attack by 
using nitric oxide as an important virulence factor.43 B. anthracis (Sterne) pre-treated with NO have 
increased viability against hydrogen peroxide exposure and a bNOS deficient strain of the bacterium has 
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increased susceptibility to attack by cultured macrophages.43 Moreover, the bNOS knockout strain of B. 
anthracis exhibits reduced virulence in mice.43 It is hypothesized that the bacterium uses NO in a dual 
mechanism to assuage attack by the host. Firstly, NO activates bacterial catalase, which decomposes 
hydrogen peroxide to water and dioxygen.43,44 Secondly, NO helps to suppress Fenton chemistry, 
thereby reducing hydroxyl radical production and subsequent nucleic acid, protein and lipid damage.43,44 
In order for Fenton chemistry to operate catalytically, the ferric iron generated in the reaction must be 
converted back to ferrous iron, a process that is accomplished by using cysteine as the reductant in 
bacteria. Nitric oxide inhibits the thioredoxin/thioredoxin reductase (Trx/TrxRed) system, the only 
system for thiol reduction in many bacteria.44 NO-mediated protection is crucial to bacterial survival 
because it does not rely on the initiation of protein synthesis, which is time- and energy-consuming. 
Instead, NO production affects the target proteins and protects the bacterial cells immediately, providing 
a valuable defense weapon for bacteria germinating inside macrophages.43,44 
The observation that NO is required for bacterial survival in a host suggests that a bNOS inhibitor 
would make a good antibacterial agent against Bacillus anthracis and related pathogens, provided that 
the compound was specific for bNOS over the eukaryotic enzymes. Bacterial NO synthase is a novel 
antibacterial target, because NO production occurs in a number of Gram-positive bacteria and, as such, 
might prove to be a general virulence factor. Because the bNOS enzyme lacks a reductase domain it is 
possible that inhibition of the reduction step would prove to be useful as a strategy for selective 
inhibition of bNOS. Using CuFL1, a protocol for measuring NO production in E. coli transfected with 
the B. anthracis bNOS was established.42 This protocol revealed that the NO production times in 
bacteria vs. macrophages are very different. The latter use inducible nitric oxide synthase (iNOS), 
which, unlike cNOSes, must be activated by immunogenic agents, such as cytokines.40 Inducible nitric 
oxide synthase is regulated at the transcription level and its basal expression levels are negligible. 
Activation involves upregulation of the iNOS mRNA, which after a few hours is translated into the 
functional enzyme.40 The different NO-production kinetics of cNOSes and iNOS offers a window of 
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opportunity for using CuFL1 to discover selective inhibitors of the former (Figure 3).43 
Chemistry of nitric oxide with non-heme iron 
In this and the following sections we turn our attention from the detection of NO to a discussion of its 
reactivity at non-heme iron sites. We focus on non-heme iron because the NO chemistry of this class of 
compounds is less developed than that of its heme-containing counterparts. Unlike the interaction of 
nitric oxide with heme iron, the chemistry of NO with non-heme iron targets in biology can result in 
dramatic modifications of the metallocofactor.45 As a consequence, detailed knowledge of 
physiologically relevant reactions at these sites is challenging to obtain because both the coordination 
number and nature of the ligands can change during reaction. Despite such challenges, studies of several 
proteins that contain non-heme iron centers have identified possible physiological roles for NO in 
transcriptional regulation46-52 and iron mobility.53-55 Non-heme iron has also been recognized as a target 
of NO toxicity.56,57 Among non-heme sites targeted by NO, iron-sulfur clusters have received special 
attention because of their propensity to react with nitric oxide and their involvement in both 
physiological and pathological processes mediated by NO.58-62 The inorganic chemistry of NO with iron-
sulfur cluster compounds has a rich history, dating back to Roussin’s preparation of the eponymous 
black salts discovered while studying the action of sulfur on solutions of sodium nitroprusside.63 Chart 1 
displays several common iron-sulfur nitrosyl compounds, many of which still bear Roussin’s name. 
In most instances, reaction of an iron-sulfur cluster protein with nitric oxide leads to disassembly of 
the Fe-S core and formation of dinitrosyl iron complexes (DNICs). DNICs can exist in a variety of 
forms (Chart 1) and oxidation states. Prototypical DNICs, which contain a single iron atom, are S = ½ 
paramagnets designated as {Fe(NO)2}9 species in the Enemark-Feltham notation.64 The doublet ground 
state gives rise to a very characteristic axial EPR signal at gav = 2.03.65 This common spectroscopic 
signature has aided the identification of DNICs in both synthetic and biological contexts, dating back 
several decades to early studies on human liver samples displaying extra-hepatic obstructive jaundice.66 
DNICs typically take the form [Fe(NO)2(X)2]−, where X is assumed to be a thiol-derived ligand such as 
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a protein-based cysteinate residue or a mobile species such as glutathione. The nature of the non-nitrosyl 
ligands in DNICs is uncertain, however, and ligand substitution reactions with N or O atom donors can 
be facile.67 The single example of a crystallographically characterized, protein-bound DNIC contains a 
tyrosinate ligand (Figure 4).68 EPR spectroscopy is not always capable of distinguishing between 
potential ligands for the {Fe(NO)2}9 fragment, and numerous examples of synthetic DNICs containing 
non-thiol ligands have been reported.69,70 
DNICs can exist in equilibrium with dimeric analogs known as Roussin’s red esters (RRE, Chart 1).71 
Several factors including solvent polarity, concentration, and the nature of the thiolate ligand can 
influence which species predominates in solution. Unlike DNICs, RRE derivatives are EPR silent due to 
antiferromagnetic coupling between the two {Fe(NO)2}9 units, which gives rise to a diamagnetic ground 
state. Consequently, identification of these species biologically is more difficult. Both UV-vis and 
Mössbauer spectroscopy have been employed to aid in the identification of protein-bound RREs,60,72 
although assignments are tenuous because many of the spectroscopic properties of the DNIC and RRE 
are similar. 
DNICs display an electrochemically reversible one-electron reduction corresponding to the 
{Fe(NO)2}9/10 couple.73 Chemical reduction of thiolate-bound DNICs, however, results in formation of 
the reduced Roussin’s red ester derivative (rRRE Chart 1).74 Certain rRREs can also exist in equilibrium 
with the corresponding DNICs by autoxidaion of the coordinating thiolate ligands.75 As with the DNIC-
RRE equilibrium, the nature of the solvent and the thiolate ligand is important in determining which 
species predominates. Not surprisingly, one-electron reduction of RRE derivatives also gives rise to the 
corresponding rRREs.76-78 Reduced Roussin’s red esters have been detected in nitrosylated protein 
samples that have been subjected to reduction.60,79 In older reports, this species was sometimes 
erroneously referred to as a “d9 DNIC”, the prototypical DNIC having been designated as a “d7 DNIC”. 
Recent work has unambiguously identified the reduced DNIC as a bimetallic species containing 
antiferromagnetically coupled {Fe(NO)2}9−{Fe(NO)2}10 centers.75 This electronic configuration gives 
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rise to an S= ½ ground state that displays an axial EPR signal centered at gav = 1.99. This signal has 
been detected when iron-sulfur clusters are exposed to NO, but only after subsequent treatment with a 
reducing agent. It therefore remains to be determined whether the presence of rRRE in protein samples 
arises from reduction of pre-existing RREs or from transformation of protein bound DNICs. 
Apart from their appearance as products of iron-sulfur cluster nitrosylation, DNICs have garnered a 
great deal of interest due to their potential role as NO storage and transfer units.80-82 The transfer of 
nitrosyl ligand(s) between metal centers is not only an intriguing reaction from the standpoint of 
inorganic chemistry but may also be an important way that biology stores the reactivity of NO for 
targeted delivery to a remote site of action. Several NO-mediated responses can be turned on with 
DNICs,83 and formation of dinitrosyl iron complexes has been suggested as a possible means of 
attenuating NO toxicity in cells.84 DNICs also play an important role in protein nitrosation,85 a reaction 
that cannot be performed by NO alone.86,87 Dinitrosyl iron complexes therefore represent an interesting 
bioinorganic cofactor, being both the end products of nitrosylation and mobile units that deliver nitric 
oxide in a controlled manner. 
Mononuclear Fe thiolates 
As an entry point into the chemistry of NO with non-heme iron, we chose to examine reactions of 
iron(II) thiolates.88 We reasoned that the reactivity of these simple complexes with NO would provide a 
framework with which to understand the chemistry of more complex iron-sulfur clusters. Treatment of 
[Fe(SR)4]2− with NO gas or the conveniently prepared thionitrite, trityl-S-nitrosothiol, leads to formation 
of the corresponding DNICs, [Fe(NO)2(SR)2]−. During the course of the reaction, Fe(II) is reduced to 
{Fe(NO)2}9, which formally contains Fe(I). The necessary reducing equivalent is provided by the 
thiolate ligand, which is converted to the disulfide. Formation of the DNIC occurs through the 
intermediacy of a mononitrosyl iron complex (MNIC), [Fe(NO)(SR)3]− (Scheme 4). This species, 
designated as {Fe(NO)}7 in the Enemark-Feltham notation, has an S = 3/2 ground-state in contrast to 
heme-type {Fe(NO)}7 species for which S = 1/2. EPR spectra of the MNIC are very similar to those 
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obtained upon treatment of mammalian ferritin with gaseous NO, suggesting that under appropriate 
biological conditions these species may form in addition to DNICs.89 Four-coordinate mononitrosyl iron 
complexes such as [Fe(NO)(SR)3]− are rare but have been known for several decades.71,90 Typically, 
thiolate-bound MNICs are challenging to isolate because of their propensity to disproportionate into 
DNICs and Fe(III) thiolates.91 If two equivalents of NO+ are used in place of NO, [Fe(SR)4]2− transforms 
to the RRE derivative (Scheme 4). This reaction also occurs via the intermediacy of the MNIC, but 
results in oxidation of additional equivalents of thiolate.92 Chemistry of the Fe(III) thiolate, [Fe(SR)4]−, 
with NO has also been examined and proceeds to the DNIC through the MNIC as with the Fe(II) 
complex.92 The reactivity of these iron thiolates demonstrates that RS− ligands are capable of providing 
the necessary reducing equivalents to transform Fe(II) or Fe(III) to {Fe(NO)2}9 species. 
Fe2S2 clusters 
The reaction of synthetic iron-sulfur clusters (both Fe2S2 and Fe4S4) with nitric oxide was first 
communicated in 1985.93 These studies demonstrated the propensity for cluster disassembly by NO gas 
and NO2−, but left unanswered the precise nature of the nitrosylation products. Subsequent work from 
our laboratory94 and elsewhere95 has definitively identified dinitrosyl iron complexes (DNICs) as the 
products of synthetic iron-sulfur cluster nitrosylation (Scheme 5). This finding appears to be general for 
a variety of synthetic Fe2S2 and Fe4S4 clusters, and is in good agreement with the large amount of data 
obtained from studies of iron-sulfur proteins. 
Oxidized versions of synthetic Fe2S2 clusters react in a straightforward manner with NO (g) or 
nitrosothiol to generate two equivalents of the respective DNIC and elemental sulfur (eq 1). 
 
 (1) 
 
Unlike the reaction of NO with homoleptic iron thiolates, [Fe(SR)4]2−/1−, which proceeds with oxidation 
of the coordinated thiolate, the NO chemistry of Fe2S2 clusters appears to involve modification of only 
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the sulfide ligands. We have not been able to observe any intermediates in this reaction nor have we 
identified the allotrope of sulfur that is formed. Addition of fewer than four equivalents of NO to 
solutions of [Fe2S2(SPh)4]2− results in a mixture of [Fe(NO)2(SPh)2]− and unreacted Fe2S2 cluster, 
suggesting that cluster disassembly by NO is rapid and that intermediate nitrosylation products are too 
unstable to observe. The elemental sulfur that is formed by destruction of the Fe2S2 cluster can further 
react with the DNIC, resulting in oxidation of the thiolate ligands and formation of the nitrosylated 
Fe4S3 cluster known as Roussin’s black salt (Chart 1).91,96 The exact stoichiometry of this reaction is 
unknown, although a formal balanced equation can be written that accounts for formation of RBS and 
disulfide (eq 2). 
 
 (2) 
 
For Fe2S2 clusters containing aryl thiolates (PhS−, p-tolylS−), subsequent oxidation of the thiolate 
ligands by sulfur is slow and the DNIC can be isolated from the reaction mixture. With alkyl thiolates 
such as [(SCH2)2-o-C6H4]2− (S2-o-xyl2−) oxidation is facile and the thiolate ligands are lost as disulfides 
resulting in formation of [Fe4S3(NO)7]−. Trapping the elemental sulfur as the phosphine sulfide can 
obviate this additional reactivity and allow for isolation of alkyl thiolate-bound DNICs.97 The fate of the 
sulfide ligands in reactions of biological iron-sulfur clusters with NO remains unknown, although the 
results with synthetic systems suggest that sulfur byproducts must be sequestered from the vicinity of 
the iron atoms in order for the DNICs to remain stable. Interestingly, the reverse of cluster nitrosylation 
has been demonstrated in aerobically growing E. coli cells in the presence of L-cysteine and cysteine 
desulfurase (IscS).98 The fact that only sulfur is required for this chemistry is consistent with results 
using synthetic clusters. Dioxygen may play an important role in these reactions, trapping NO as NO2 or 
other nitrogen oxides and effectively removing NO. The synthetic cluster, [Fe2S2(S5)2]2−, can be 
regenerated from the DNIC, [Fe(NO)2(S5)]−, in the presence of S8 and Fe(1,2-benzenedithiolate)2, which 
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serves as a trap for NO.95 Transformation of the synthetic DNIC, [Fe(NO)2(SEt)2]−, into the 
corresponding Fe2S2 cluster can also occur via the intermediacy of Roussin’s red salt (Chart 1).97 
Because this chemistry requires additional thiolate equivalents in the form of [Fe(SR)4]−, it is unlikely to 
be a true model of Fe2S2 repair in vivo, albeit a most interesting reaction. 
Fe4S4 clusters 
Reaction pathways of synthetic Fe4S4 clusters with nitric oxide are more difficult to describe in detail 
because of the added complexity of the larger {Fe4S4}2+ core. Reaction of Fe4S4 clusters from 
aconitase,79 HiPIP,60 and endonuclease99 with nitric oxide all lead to formation of protein bound DNICs. 
As with Fe2S2 clusters, the repair of Fe4S4 clusters by DNICs has been demonstrated in both protein and 
synthetic systems.99,100 Our investigations of the reactivity of several synthetic Fe4S4 clusters with 
varying equivalents of NO gas or trityl-S-nitrosothiol revealed the thermodynamically stable Roussin’s 
black salt to be the major product of cluster nitrosylation (Scheme 5).94 Both the corresponding DNIC 
and the nitrosylated Fe4S4 clusters, [Fe4S4(NO)4]n− (n = 1, 2),100,101 were also detected in minor quantities 
by IR spectroscopy. Whether or not these mononitrosyl iron-sulfur clusters represent intermediates in 
the conversion of [Fe4S4(SR)4]2− to RBS100 or result from alternative reaction pathways is not known. In 
all cases, the corresponding disulfides were isolated as reaction products, indicating that the thiolate 
ligands were oxidized in the process. These results stand in contrast to work with Fe4S4 cluster proteins, 
where treatment with NO leads to the formation of protein-bound DNICs. However, when the reaction 
of NO with the prototypical synthetic cluster [Fe4S4(SPh)4]2− was carried out in the presence of added 
PhS−, [Fe(NO)2(SPh)2]− was detected as the major iron-containing reaction product. These results again 
suggest that at least two thiolate ligands are required to stabilize DNICs and prevent further reactivity in 
the presence of elemental sulfur. By comparison, when the sulfide-free Fe4 cluster, [Fe4(SPh)10]2−, was 
treated with NO, the DNIC and RRE were formed in a 2:1 ratio (eq 3), consistent with the thiolate 
ligands providing all of the necessary reducing equivalents. 
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 (3) 
 
It therefore appears that in both Fe2S2 and Fe4S4 clusters the sulfide ligands are oxidized during 
disassembly of the Fe-S core. Without a means of sequestering the sulfur byproducts, however, the 
resulting DNICs react further with elemental sulfur to form the thermodynamically stable Roussin’s 
black salt. RBS is toxic to living cells and without ligand substitution lacks an available site for 
attachment to proteins.45 It is therefore unlikely that RBS plays an important role in biological iron-
sulfur cluster nitrosylation. As observed with HiPIP from C. vinsoum, iron can be lost during 
nitrosylation of protein-bound Fe4S4 clusters, resulting in a thiolate-to-iron ratio sufficient to stabilize 
DNICs against transformation to RBS. 
Non-thiolate Fe2S2 clusters 
While studying the reactions of synthetic Fe2S2 clusters, we discovered that the abiological cluster, 
[Fe2S2Cl4]2−, reacts with NO in a fashion identical to that of its [Fe2S2(SR)4]2− thiolate analogues (eq 
4).102  
 
 (4) 
 
This result suggested a commonality in the chemistry of compounds containing the {Fe2S2}2+ core with 
nitric oxide. In a biological context, very little work has been devoted to the reactivity of nitric oxide 
with iron-sulfur clusters containing non-thiolate ligands.103 Such reactions are of interest because a 
variety of important Fe2S2 clusters contain at least one non-cysteinate ligand.104 Furthermore, many 
potentially ligating amino acid residues other than cysteine lack the capacity for redox chemistry and 
therefore may display different chemistry in reactions with NO. Based on our results with the thiolate- 
and chloride-bound Fe2S2 clusters, we hypothesized that the chemistry of other Fe2S2 might be expected 
to follow the same pathway outlined in eq 4. Indeed, we discovered that a synthetic Rieske-type Fe2S2 
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cluster, [Fe2(μ-S)2(BIPM)(S2-o-xyl)]2−,105 could be nitrosylated to the corresponding N-bound and S-
bound DNICs (Scheme 6).102 
Although many examples of DNICs coordinated by nitrogen-donor ligands exist, [Fe(NO)2(BIPM)]− is 
the first such complex to be prepared by nitrosylation of an iron-sulfur cluster.67,106-110 As for 
prototypical DNICs, [Fe(NO)2(BIPM)]− demonstrates a reversible one-electron reduction in acetonitrile 
at −1.98 V (vs Fc/Fc+), assigned to the {Fe(NO)2}9/10 couple (Figure 5). Unlike DNICs containing 
thiolate ligands, DNICs containing nitrogen ligands might be expected to undergo redox reactions 
without decomposition because of a lesser propensity for ligand oxidation. With a related DNIC 
containing a 2,6-diisopropylphenyl-substituted β-diketiminate ligand we isolated a homologous set of 
{Fe(NO)2}9/10 redox partners (Figure 6). These species will facilitate investigations into how changes in 
the redox state of the DNIC influences both structure and reactivity, particularly in NO transfer 
processes. Such a redox switch would be a useful means by which nature could control the storage and 
release of NO equivalents from DNICs. 
 
Conclusions and Outlook 
Detailed knowledge of the chemical reactivity of nitric oxide in the biological milieu is required for a 
complete understanding of its physiology and pathology. We have explored this reactivity by identifying 
where NO is produced and how it is utilized in cells using fluorescent probes and, in biomimetic 
chemistry, by investigating the fundamental inorganic chemistry of NO with iron-sulfur protein active 
site models. This dual approach is well suited to the study of small molecules of biological interest like 
nitric oxide, and we envision that it may also be successful in studies of other such species including 
peroxynitrite, nitroxyl, carbon monoxide, and hydrogen sulfide. 
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Figure 1. (a) CuFL1 detection of NO in SK-N-SH neuroblastoma cells. [CuFL1] = 1 μM, [17β-
estradiol] = 100 nM. From left to right: 25 min exposure to CuFL1, no 17β-estradiol; 5 min; 10 min; 15 
min; 25 min exposure to CuFL1 and 17β-estradiol. Top: Fluorescence images; Bottom: DIC images. 
Scale bars = 50 μm. (b) CuFL1 detection of NO in Raw 264.7 murine macrophages. [CuFL1] = 1 μM, 
[lipopolysaccharide (LPS)] = 500 ng/mL, [interferon- γ (IFN-γ)] = 250 U/mL. From left to right: 12 h 
exposure to CuFL1, no LPS/IFN-γ; 6 h; 8 h; 10 h; 12 h exposure to CuFL1 and LPS/IFN-γ. Top: 
Fluorescence images; Bottom: DIC images. Scale bars = 50 μm. For additional details see ref. 32 
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Figure 2. (a) Relative energies of the molecular orbitals for the ground states of FL1 (left) and FL1-NO 
(right). (b) Qualitative molecular orbital diagram for the ground (left), excited (middle), and charge-
transfer (right) states of FL1. R1 = 2-methylquinoline; R2 = fluorophore. For additional details see ref. 
31. 
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Figure 3. Visualization of fluorescence enhancement by CuFL1 in J774A.1 infected macrophages at 2 
and 18 h post-infection. Top row: bNOS-expressing B. anthracis (Sterne) cells taken up by 
macrophages. Sterne cells produce NO using bNOS within 2 h of uptake. The host macrophages 
produce NO using iNOS between 2 and 18 h. Middle row: bNOS-deficient B. anthracis cells taken up 
by macrophages. No fluorescence is observed after 2 h because these bacteria cannot generate NO. The 
host macrophages produce NO using iNOS as usual. Bottom row: Control, no bacteria and no induction 
of iNOS 
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Figure 4. Structure of human glutathione S-transferase P1-1 monomer containing a bound dinitrosyl 
iron complex. Coordinates were taken from PDB code 1ZGN; for additional details see ref. 68. 
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Figure 5. Cyclic voltammogram of (Et4N)[Fe(NO)2(BIPM)] displaying the reversible {Fe(NO)2}9/10 
couple. Conditions: 3 mM in CH3CN; glassy carbon electrode; 0.1 M Bu4NPF6 electrolyte; 100 mV/s 
scan rate. 
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 Stotal νNO (cm-1) δ (mm/s) ΔEQ (mm/s) avg. dFe-N(O) (Å) avg. dN-O (Å) 
{Fe(NO)2}9 ½ 1761, 1709 0.19(2) 0.79(2) 1.692(2) 1.175(2) 
{Fe(NO)2}10 0 1627, 1567 0.22(2) 1.31(2) 1.656(5) 1.205(6) 
 
Figure 6. Comparison of selected spectroscopic and structural properties for two homologous DNIC 
redox partners. Thermal ellipsoids are drawn at 50% probability. Hydrogen atoms and the PPN+ cation 
in the {Fe(NO)2}10 structure are omitted for clarity. For additional details see ref. 102. 
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Scheme 1. 
 
 
 
Scheme 2. 
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Scheme 3. 
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Scheme 4. 
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Scheme 5. 
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Scheme 6. 
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Chart 1. Common {Fe(NO)2}9-containing species. 
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TOC GRAPHIC 
 
SYNOPSIS: A dual strategy for investigating the chemistry of nitric oxide as a biological signaling 
agent is described. In one approach, metal-based fluorescent sensors for the detection of NO in living 
cells are devised and evaluated. In the other approach, synthetic model complexes of the active sites of 
iron-sulfur proteins are employed to probe their reactivity toward nitric oxide. 
 
